Skip to main content

Germany's biotechnology industry takes off

The German government has just announced a $425 million, three-year genome research funding program. This type of government support, and the revision of federal laws are promoting a growth spurt in the German biotechnology industry.

Written byJohn Borchardt
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

HOUSTON German political leaders pledged increased support for genome research last week. Edelgard Bulmahn, German minister for Education and Research said the government will devote 870 million marks ($425 million) to genome research over the next three years. This more than doubles the ministry's earlier four-year funding program announced in 2000.

After World War II, Germany's medical, pharmaceutical and genetic research industries were restricted by laws that made it difficult to set up new biotechnology laboratories or production plants. These laws did not change much until 1993. The Green Party has also been quite hostile to biotechnology for both pharmaceutical and agricultural applications. For example, in the late 1980s it opposed construction of a Bayer plant that would manufacture a genetically engineered protein for haemophiliacs. Bayer built the plant, which employs 1,300 people, in the US. Until the late 1990s, the climate for the biotechnology industry in Germany was such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo